title: Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm.
authors.forename: Luis V
authors.initials: LV
authors.lastname: Syro
authors.forename: Humberto
authors.initials: H
authors.lastname: Uribe
authors.forename: Luis C
authors.initials: LC
authors.lastname: Penagos
authors.forename: Leon D
authors.initials: LD
authors.lastname: Ortiz
authors.forename: Camilo E
authors.initials: CE
authors.lastname: Fadul
authors.forename: Eva
authors.initials: E
authors.lastname: Horvath
authors.forename: Kalman
authors.initials: K
authors.lastname: Kovacs
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000473:pathology; D015175:Prolactinoma / Q000188:drug therapy* / Q000473:pathology; D000077204:Temozolomide
chemical_list: D000970:Antineoplastic Agents; D003606:Dacarbazine; D000077204:Temozolomide